Doxorubicin Hydrochloride
- Product NDC
- 0069-3032
- 11-digit product format
- 000693032
- Labeler code
- 0069
- Product ID
- 0069-3032_347b56fa-d8d4-4fa8-aa2c-364b3a0c1799
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxorubicin Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- NDA050629
- Marketing category
- NDA
- Marketing start
- 1987-12-23
- Marketing end
- 0000-00-00
- Substance
- DOXORUBICIN HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [CS],Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 0069-3032 | D | Discontinued by firm | 2026-08-03 | ||
| excluded package | package | 0069-3032 | 0069-3032-20 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050629-001 | DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 |
| N050629-002 | DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 |
| N050629-003 | DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N050629-001 | AP |
| N050629-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050629-002 | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | RLD, RS | 1988-05-03 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050629-003 | DOXORUBICIN HYDROCHLORIDE | 150MG/75ML | INJECTABLE / INJECTION | RLD | 2011-03-28 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N050629-001 | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS | 1987-12-23 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N050629-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N050629-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050629-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050629-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N050629-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N050629-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050629-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050629-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050629-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050629-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050629-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050629-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050629-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050629-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050629-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050629-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050629-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050629-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N050629-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N050629-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050629-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050629-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050629-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050629-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050629-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050629-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N050629-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N050629-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050629-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050629-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N050629-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N050629-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N050629-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N050629-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N050629-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N050629-002 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N050629-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N050629-002 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N050629-001 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N050629-002 | AP | 1 | 782e0a99824c… |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0069-3032-20 | Doxorubicin Hydrochloride | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 28 | |
| 0069-3032-20 | Doxorubicin Hydrochloride | 25 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 25 | 28 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0069-3032-20 | ML - Milliliter | 0069-3032 | a76ab83a-0c2c-4096-acde-8290f429c824 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DOXORUBICIN HYDROCHLORIDE | ACTIVE INGREDIENT | 82F2G7BL4E | DOXORUBICIN HYDROCHLORIDE INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 11 | |
| DOXORUBICIN | ACTIVE MOIETY | 80168379AG | DOXORUBICIN HYDROCHLORIDE INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 11 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | DOXORUBICIN HYDROCHLORIDE INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 11 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | DOXORUBICIN HYDROCHLORIDE INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 11 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Pfizer Laboratories Div Pfizer Inc | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | 050629 NDA050629 0069-3032 |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Pfizer Laboratories Div Pfizer Inc | 00634b2b-4e48-4178-8877-28582af894ad | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 050629 NDA050629 |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Pfizer Laboratories Div Pfizer Inc | d31d7f58-66d0-4826-b6b5-5914c031965f | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | 050629 NDA050629 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1790097 | DOXOrubicin HCl 10 MG in 5 mL Injection | PSN | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 28 |
| 1191138 | DOXOrubicin HCl 2 MG/ML Injectable Solution | PSN | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 28 |
| 1790099 | DOXOrubicin HCl 20 MG in 10 ML Injection | PSN | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 28 |
| 1790100 | DOXOrubicin HCl 50 MG in 25 ML Injection | PSN | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 28 |
| 1790099 | 10 ML doxorubicin hydrochloride 2 MG/ML Injection | SCD | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 28 |
| 1790100 | 25 ML doxorubicin hydrochloride 2 MG/ML Injection | SCD | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 28 |
| 1790097 | 5 ML doxorubicin hydrochloride 2 MG/ML Injection | SCD | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 28 |
| 1191138 | doxorubicin hydrochloride 2 MG/ML Injectable Solution | SCD | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 28 |
| 1790097 | doxorubicin hydrochloride 10 MG per 5 ML Injection | SY | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 28 |
| 1790099 | doxorubicin hydrochloride 20 MG per 10 ML Injection | SY | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 28 |
| 1790100 | doxorubicin hydrochloride 50 MG per 25 ML Injection | SY | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 28 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0069-3032-20 | 00069303220 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-3032-20) > 25 mL in 1 VIAL, SINGLE-DOSE | 1987-12-23 | 0000-00-00 | No | No | Current |